| Value | ₹5.00 Cr |
|---|
BSE filing, NSE: SHRINGARMS. Summary written from the filing by ALFA Finder's alert engine.
Shringar House of Mangalsutra Ltd: key numbers
- Share price
- ₹290.40
- Market cap
- ₹2,800 Cr
- Revenue (annual)
- ₹2,246 Cr
- Net profit (annual)
- ₹115.5 Cr
- P/E (TTM)
- 23.1×Sector 33.3×
- Promoter holding
- 74.80%+0.00% QoQ
- FII holding
- 3.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shringar House of Mangalsutra Ltd
All →Shringar House of Mangalsutra Results Update
Shringar House of Mangalsutra issued a press release on Q2 FY27 results, with revenue up 54.8% year on year. Profit after tax rose 73.2% in the quarter.
Shringar House of Mangalsutra Investor Presentation: Key Takeaways
H1 FY27 revenue ₹1,367 Cr (+58.7%), PAT ₹73.5 Cr (+43.1%), EBITDA margin 7.6%. Q2 FY27 revenue ₹819 Cr (+55%), PAT ₹39 Cr (+73%). Bridal jewellery entry; new 4,000 kg capacity.
Shringar House of Mangalsutra Other Announcement
Shringar House of Mangalsutra filed its Monitoring Agency Report on IPO proceeds for the quarter ended 30 September 2026. The report shows no deviation from objects.
Shringar House of Mangalsutra Q2 FY27 Results: Net Profit ₹39.5 Cr, Up 73.2% YoY
Shringar House of Mangalsutra approved unaudited standalone financial results for the quarter and half year ended September 30, 2026. The Board meeting concluded on November 4, 2026.
- Key figure
- Net profit ₹39.5 Cr · +73.2% YoY
Shringar House of Mangalsutra Board Meeting Date
Shringar House of Mangalsutra Ltd intimated a board meeting on 04 November 2026 to consider standalone unaudited financial results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results announcement.
Shringar House of Mangalsutra Price Movement Clarification
Shringar House of Mangalsutra clarified that it is in compliance with SEBI regulations and aware of no undisclosed material information affecting its share price movement.
Other merger & restructuring announcements
All →Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr
Saregama India Merger & Restructuring
Saregama India's board approved closing its wholly owned Dubai subsidiary, Saregama FZE, which has no ongoing operations. The closure is not expected to materially affect business operations.
Jindal Poly Films Merger & Restructuring
Jindal Poly Films' step-down subsidiary, JPF API Laminates UK Limited, was dissolved effective November 3, 2026. It has ceased to be a subsidiary of the company.
Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹2.1 Cr
Clean Max Enviro will incorporate a wholly owned IFSC subsidiary for Global Treasury Centre activities. It will subscribe 21,00,000 shares for ₹2.10 Crore in cash.
- Value
- ₹2.10 Cr